LLY

40 Upgrades and Downgrades for this Week

It pays to stay on top of the latest profit opportunities, and today's post is a great place to start. Here are Portfolio Grader's latest stock updates More 

3 Big Pharma Stocks Under the Microscope: BMY, ABBV, LLY

Are prevailing concerns about big pharma stocks taking their toll, or are LLY, BMY and ABBV showing their strength anyway? More 

3 Fantastic Blue Chips to Avoid (For Now)

JNJ, LLY and BMY are all reliable blue chips, but their current valuation makes them a poor investment right now. More 

Mid-Day Report: Market Focus Is Divided Between Fed & Q1 Earnings

The major indexes started the day with a bang but have given ground as the mood remains tentative given the Fed meeting and Apple's earnings due later today More 

Eli Lilly and Co (LLY) Stock Drops on Q1 Earnings

Eli Lilly stock was down on Tuesday after it released its Q1 earnings report with EPS that didn't match up to Wall Street's expectations. More 

Trade of the Day: Halozyme Therapeutics, Inc. (NASDAQ:HALO)

he current market cap for Halozyme Therapeutics (HALO) is at $1.5 billion, which makes it ripe as a takeover target. More 

3 Big Pharma Stocks to Buy, 3 to Avoid

Big Pharma stocks are under pressure as regulation threatens to curb drug prices and tax driven mergers are intercepted by the treasury. More